Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 9, 2008

View Archived Issues

New agents for treating neurological disorders disclosed in recent patent literature

Biolex signs agreement with OctoPlus to acquire 50% share of hepatitis C drug Locteron

Weight loss, increased urine output seen with lixivaptan in chronic heart failure patients

MolMed's partner Takara Bio starts phase I trial of TK for leukemia in Japan

Pipex Pharmaceuticals receives approval to initiate phase II oral flupirtine trial

Merck & Co. to evaluate use of once-daily raltegravir in HIV patients

Vical and AnGes sign letter of intent for pandemic influenza DNA vaccines in Japan

Comparative trial shows utility of biolimus-eluting stent with biodegradable polymer

Lux licenses from Isotechnika global rights to voclosporin in all ophthalmic indications

Hemispherx Biopharma seeking corporate partner for Ampligen

DSMB recommends continuation of BioMS Medical's phase II MINDSET-01 trial of dirucotide in MS

Recent patents describe new agents for diabetes and associated disorders

EMEA withdraws marketing authorization for Protopy in the European Union

Novel antiinfective agents disclosed in recent patents

Alnylam earns technology transfer milestone payment from Takeda

Phase I data on intravenous CP-4126 in solid tumors support phase II investigation

GSK-256066 inhibits allergen challenge responses in patients with asthma

FDA approves Akten ophthalmic gel 3.5%

FoldRx reports progress for Fx-1006A development program

Morria Biopharmaceuticals reports results from preclinical screening of antiinflammatory compounds

Novacta achieves first milestone in strategic translational award received from Wellcome Trust

R&D highlights from the UBS Global Life Sciences Conference in New York: Osiris Therapeutics

EpiCept receives marketing approval in Europe for Ceplene

Incyte reports safety and efficacy for INCB-018424 in proof-of-concept psoriasis study

Watson receives FDA approval for Rapaflo for benign prostatic hyperplasia

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...